Philips and MEDSI to Enter New Healthcare Technology Partnership in Russia

PhilipsRoyal Philips (NYSE: PHG, AEX: PHIA) and MEDSI, Russia's largest network of private clinics, announced a strategic partnership to develop a clinical network aimed at providing efficient medical care in Russia. MEDSI president Alexey Chupin, and Peter Vullinghs, CEO of Philips in Russia and the Commonwealth of Independent States (CIS) have signed a Memorandum of Understanding (MOU) in Davos during a ceremony attended by Vladimir Evtushenkov, Chairman of the Board of Directors of Sistema Joint-Stock Financial Corporation (JSFC), and Frans van Houten, CEO of Royal Philips.

Philips and MEDSI, a leading provider of patient-centered quality care in Russia, will cooperate to achieve operational excellence at MEDSI's healthcare facilities. This new partnership goes beyond the traditional supply of innovative medical equipment and advanced technologies. It includes the access to Philips' international expertise in hospital management and the company’s conceptual understanding of hospital settings. The financial details of the partnership will not be disclosed.

The comprehensive multi-year partnership will provide MEDSI hospitals with guaranteed affordable access to the latest Philips healthcare equipment and technology, enabling MEDSI to focus on the delivery of high quality care. Philips will manage the technology and its operational performance, and provide performance management consultancy services in order to support enhanced quality of care. This business model will allow the hospitals involved to optimize their infrastructure management, patient flows and processes, and receive continuous training as well as regular system and software upgrades from Philips.

"Philips will be one of the first companies in Russia to manage such a large-scale project by providing a unified hospital solution that includes everything from design, equipment, service, patient flow management, clinical performance improvement and overall hospital management," said Peter Vullinghs. "We are extremely delighted to enter into this innovative partnership with MEDSI - the leading private healthcare provider in Russia and a very effective and dynamic organization."

"Signing of this cooperation agreement is an important step forward in MEDSI's business development and closely corresponds to our strategy of extending our clinical network and enhancing the quality of our medical services," said Alexey Chupin. "We have already achieved some good results towards this goal, and in partnership with Philips we believe we can do even more to turn our hospitals into high-tech medical institutions, where patients will receive high quality effective care based on early diagnostics in accordance with the best international quality standards."

Philips and MEDSI will cooperate in the areas of hospital renovation, full technical re-equipment of a MEDSI Clinical Hospital in Moscow's suburban area, and the building of a new clinical diagnostics center for children and adults, including a short-term in-patient hospital and children's clinical hospital. The partnership also extends to a multi-profile clinical diagnostics center for children and adults with a daytime in-patient hospital, which will be built as part of MEDSI's Clinical Hospital on Michurinsky Avenue, Moscow. It is envisaged that this complex will become a flagship hospital for the MEDSI network, showcasing the latest trends and conceptual ideas in organizing and operating a hospital.

Related news articles:

About Royal Philips
Royal Philips (NYSE: PHG, AEX: PHIA) is a diversified health and well-being company, focused on improving people’s lives through meaningful innovation in the areas of Healthcare, Consumer Lifestyle and Lighting. Headquartered in the Netherlands, Philips posted 2012 sales of EUR 24.8 billion and employs approximately 114,000 employees with sales and services in more than 100 countries. The company is a leader in cardiac care, acute care and home healthcare, energy efficient lighting solutions and new lighting applications, as well as male shaving and grooming and oral healthcare.

About MEDSI Group of Companies
The MEDSI Group of Companies is a leading national provider of medical and healthcare services in Moscow and other regions. Its network comprises 30 medical centers, of which 19 are in Moscow and the surrounding region and 11 in other parts of Russia. The Group's facilities include a clinical and diagnostic center at Belorusskaya, MEDSI International Clinic, two children's clinics and a network of fitness and wellness clubs.

Most Popular Now

Unlocking the 10 Year Health Plan

The government's plan for the NHS is a huge document. Jane Stephenson, chief executive of SPARK TSL, argues the key to unlocking its digital ambitions is to consider what it...

Alcidion Grows Top Talent in the UK, wit…

Alcidion has today announced the addition of three new appointments to their UK-based team, with one internal promotion and two external recruits. Dr Paul Deffley has been announced as the...

AI can Find Cancer Pathologists Miss

Men assessed as healthy after a pathologist analyses their tissue sample may still have an early form of prostate cancer. Using AI, researchers at Uppsala University have been able to...

AI, Full Automation could Expand Artific…

Automated insulin delivery (AID) systems such as the UVA Health-developed artificial pancreas could help more type 1 diabetes patients if the devices become fully automated, according to a new review...

How AI could Speed the Development of RN…

Using artificial intelligence (AI), MIT researchers have come up with a new way to design nanoparticles that can more efficiently deliver RNA vaccines and other types of RNA therapies. After training...

MIT Researchers Use Generative AI to Des…

With help from artificial intelligence, MIT researchers have designed novel antibiotics that can combat two hard-to-treat infections: drug-resistant Neisseria gonorrhoeae and multi-drug-resistant Staphylococcus aureus (MRSA). Using generative AI algorithms, the research...

AI Hybrid Strategy Improves Mammogram In…

A hybrid reading strategy for screening mammography, developed by Dutch researchers and deployed retrospectively to more than 40,000 exams, reduced radiologist workload by 38% without changing recall or cancer detection...

Penn Developed AI Tools and Datasets Hel…

Doctors treating kidney disease have long depended on trial-and-error to find the best therapies for individual patients. Now, new artificial intelligence (AI) tools developed by researchers in the Perelman School...

New Training Year Starts at Siemens Heal…

In September, 197 school graduates will start their vocational training or dual studies in Germany at Siemens Healthineers. 117 apprentices and 80 dual students will begin their careers at Siemens...

Are You Eligible for a Clinical Trial? C…

A new study in the academic journal Machine Learning: Health discovers that ChatGPT can accelerate patient screening for clinical trials, showing promise in reducing delays and improving trial success rates. Researchers...

New AI Tool Addresses Accuracy and Fairn…

A team of researchers at the Icahn School of Medicine at Mount Sinai has developed a new method to identify and reduce biases in datasets used to train machine-learning algorithms...

Global Study Reveals How Patients View M…

How physicians feel about artificial intelligence (AI) in medicine has been studied many times. But what do patients think? A team led by researchers at the Technical University of Munich...